Biotech5 months ago
Esteve Completes the Purchase of HRA Pharma Rare Diseases for 275 Million
Esteve has expanded internationally by acquiring HRA Pharma Rare Diseases from Perrigo Company plc, adding three drugs for treating Cushing's syndrome and adrenocortical carcinoma. This €275...